Verisk Analytics Inc. stock underperforms Friday when compared to competitors
Verisk Analytics Inc. (VRSK) shares fell 3.66% to $195.88 on Friday, ending a three-day winning streak, while the broader market also declined.
Verisk Analytics, Inc.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Verisk Analytics Inc. (VRSK) shares fell 3.66% to $195.88 on Friday, ending a three-day winning streak, while the broader market also declined.
RBC Capital reiterated an Outperform rating and $230 price target for Verisk Analytics (VRSK) after a court ruling on its AccuLynx acquisition. The Delaware Supreme Court ordered Verisk to pursue FTC approval and close the $2.35B deal, awarding AccuLynx costs. Verisk will comply, with the transaction subject to FTC review. The deal may constrain share buybacks and increase leverage. Verisk's Q2 earnings and revenue slightly beat estimates, and BMO Capital raised its price target to $248.
RBC Capital maintained an Outperform rating and $230 price target for Verisk Analytics (VRSK), citing undervaluation and growth prospects. The company expects 7% Q3 2026 organic revenue growth, driven by government contracts and GenAI adoption. Verisk reported Q2 earnings and revenue slightly above estimates, with a P/E ratio of 27.87. BMO Capital raised its price target to $248. The company is appealing a court decision related to its acquisition of AccuLynx.
Over the past 7 days, AlphAI's AI scored 5 news stories mentioning VRSK (Verisk Analytics, Inc.). Coverage has skewed bearish: 0 bullish, 3 neutral, and 2 bearish.
Recent VRSK coverage spans financial news, market movers and mergers & acquisitions.
In the last 30 days, VRSK insiders filed 2 SEC Form 4 transactions — no purchases and 2 sales ($677K). The most active reporter was Mann Elizabeth, Chief Financial Officer, with 1 filing. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.
The stock's decline suggests short‑term pressure without a clear catalyst.
The forced deal adds debt, likely pressuring the stock lower as investors price in higher leverage and limited buybacks.
Street valuation support remains constructive, but the article is primarily an analyst reiteration rather than a new company catalyst.
The article is a fresh catastrophe-loss modeling update from Verisk’s Catastrophe and Risk Solutions unit, relevant to insurers’ loss expectations and risk pricing.
The target cut suggests a weaker outlook for Verisk, likely pressuring the stock lower.
AlphAI scores every news story that mentions VRSK with an AI model for sentiment and relevance, and aggregates insider trades from Verisk Analytics, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Verisk Analytics Inc. (VRSK) shares fell 3.66% to $195.88 on Friday, ending a three-day winning streak, while the broader market also declined.
1 min readRBC Capital reiterated an Outperform rating and $230 price target for Verisk Analytics (VRSK) after a court ruling on its AccuLynx acquisition. The Delaware Supreme Court ordered Verisk to pursue FTC approval and close the $2.35B deal, awarding AccuLynx costs. Verisk will comply, with the transaction subject to FTC review. The deal may constrain share buybacks and increase leverage. Verisk's Q2 earnings and revenue slightly beat estimates, and BMO Capital raised its price target to $248.
2 min readRBC Capital maintained an Outperform rating and $230 price target for Verisk Analytics (VRSK), citing undervaluation and growth prospects. The company expects 7% Q3 2026 organic revenue growth, driven by government contracts and GenAI adoption. Verisk reported Q2 earnings and revenue slightly above estimates, with a P/E ratio of 27.87. BMO Capital raised its price target to $248. The company is appealing a court decision related to its acquisition of AccuLynx.
4 min readVerisk (VRSK) estimates Hurricane Isaias caused $1B-$2B in insured losses, mostly from wind. The storm made landfall in Florida as a Category 2 hurricane, causing widespread damage. The estimate excludes flood losses and other specific exclusions.
4 min readVerisk Analytics' average price target was reduced by analysts from $233.47 to $232.29, suggesting a 31% upside from its Oct. 12 closing price. The consensus rating remains 'Buy' among 23 analysts.
1 min readDeutsche Bank reduced its price target for Verisk Analytics from $225 to $200. The stock is currently trading at $176.68, up 0.68% on the day and down 21.55% over the year. Evercore ISI also adjusted its target to $223 from $222.
1 min readShavel Lee (Chief Executive Officer) sold 3,535 shares of Verisk Analytics, Inc. (VRSK) at $170.70 ($0.60M total) on 2026-10-01 under a Rule 10b5-1 trading plan.
1 min readVerisk Analytics officer Lee Shavel plans to sell 3,535 shares worth $603K on October 1, 2026, via a broker-assisted cashless sale after exercising stock options. Earlier sales of 2,500 and 3,535 shares were made in July, August, and September 2026.
1 min readVerisk Analytics (VRSK) integrated Truepic's image and video authentication tools into its ClaimSearch platform, enhancing fraud detection for insurers. This move aligns with Verisk's strategy to improve claims decisioning and productivity. Analysts project revenues of $3.8B and earnings of $1.3B by 2029, with a 6.6% annual revenue growth rate. The integration is seen as incremental but fits into Verisk's broader AI and automation focus.
3 min readVerisk Analytics (VRSK) launched Verisk Fraud Discovery, a fraud prevention platform adopted by Hiscox, Allianz, and Weightmans. The platform may deepen client reliance on Verisk's data tools. Analysts project $3.8B revenue and $1.3B earnings by 2029, with 6.7% annual growth. Investors should watch insurer budgets and macroeconomic factors.
3 min read